AMOREMEDIX MEDICAL GROUP
A Different Approach to Depression Treatment
When depression has not improved with traditional treatments, there may be another option. AmoreMedix Medical Group offers SPRAVATO® (esketamine) treatment for eligible adults with treatment-resistant depression in a comfortable, medically supervised outpatient setting.
CHECK INSURANCE COVERAGE
You Have Options Beyond Traditional Antidepressants
Depression can be especially frustrating when you have tried medications, therapy, or different treatment combinations and still do not feel like yourself.
SPRAVATO® is an FDA-approved prescription nasal spray that works differently from traditional antidepressant medications and may be an option for certain adults with treatment-resistant depression.
At AmoreMedix, our goal is to make the process understandable, comfortable, and medically supported from your initial evaluation through ongoing treatment.
What Is SPRAVATO®?
SPRAVATO® contains esketamine and is administered as a nasal spray under the supervision of a healthcare provider. Unlike many traditional antidepressants that primarily target serotonin, norepinephrine, or dopamine pathways, esketamine acts primarily through the glutamate system.
SPRAVATO® is FDA approved for the treatment of treatment-resistant depression in adults, either as monotherapy or together with an oral antidepressant. It is also FDA approved, in conjunction with an oral antidepressant, for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior.
Not everyone is an appropriate candidate. An AmoreMedix provider will review your medical history, current medications, previous depression treatments, and overall health to determine whether SPRAVATO® may be appropriate for you.
What Treatment at AmoreMedix Looks Like
1.
Initial Consultation
Your care begins with a comprehensive evaluation. We will discuss your symptoms, treatment history, current medications, medical history, and your goals for treatment.
2.
Insurance & Authorization
Our team will review your insurance benefits and, when applicable, work through the prior authorization process required by your insurance plan.
3.
Your Treatment Visit
SPRAVATO® is administered by you as a nasal spray while under medical supervision at our office.
Your healthcare team will monitor you throughout your visit, including appropriate vital signs and assessment for potential side effects.
4. Comfortable Observation
After receiving SPRAVATO®, you will remain at the clinic for at least two hours for monitoring. We want this portion of your visit to feel calm and comfortable.
Patients can relax while our clinical team remains available and monitors their response to treatment.
5.
Ongoing Care
Treatment frequency generally changes over time based on the recommended treatment schedule, your clinical response, tolerability, and your provider’s assessment.
We will continue to evaluate your symptoms and progress throughout treatment.
Your SPRAVATO® Treatment Schedule
For treatment-resistant depression, treatment typically begins with an induction phase involving more frequent appointments, followed by progressively less frequent treatments when clinically appropriate.
Your exact treatment plan will be determined by your healthcare provider based on your diagnosis, response, tolerability, and individual needs.
A Treatment Environment
Designed Around You
Receiving mental health treatment should not feel cold or institutional. The AmoreMedix SPRAVATO® program is designed to provide a private, comfortable environment where patients can receive treatment while being appropriately monitored by their healthcare team.
• Comfortable treatment space
• Medical supervision throughout treatment
• Individualized treatment planning
• Insurance verification and prior authorization assistance
• Ongoing symptom and response monitoring
Is SPRAVATO® Right for Me?
SPRAVATO® may be considered for adults with treatment-resistant depression who have not experienced adequate improvement with previous antidepressant treatment. 3 Eligibility is determined through an individual clinical evaluation.
Certain medical conditions, medications, pregnancy considerations, blood pressure concerns, substance-use history, and other factors may affect whether SPRAVATO® is appropriate for you.
The first step is simply having a conversation with one of our providers.
Preparing for Treatment
Because SPRAVATO® can temporarily affect alertness, perception, coordination, and blood pressure, patients are monitored for at least two hours following administration.
You cannot drive yourself home following treatment. Patients should arrange transportation home and should not drive, operate machinery, or participate in activities requiring complete alertness until the following day after a restful night’s sleep.
Additional preparation instructions will be provided before your first treatment.
Insurance & Cost
SPRAVATO® is covered by many commercial insurance plans and may also be covered by Medicare or Medicaid plans depending on eligibility, diagnosis, plan requirements, and medical necessity.
Coverage varies. Our team can help determine your benefits, review authorization requirements, and explain expected patient responsibility before treatment whenever possible.
Have insurance? Let us check your benefits.
Referring Providers
AmoreMedix Medical Group welcomes referrals from psychiatrists, psychiatric nurse practitioners, primary care providers, therapists, and other healthcare professionals.
We can provide SPRAVATO® administration and monitoring while coordinating with the patient’s existing mental health treatment team when appropriate.
Frequently Asked Questions
Is SPRAVATO® the same as ketamine?
No. SPRAVATO® contains esketamine, which is related to ketamine but is a distinct medication.
SPRAVATO® is FDA-approved for specific depressive disorders and is administered under a federally
4 required safety program.
How long should I expect to be at the office?
Patients must be observed for at least two hours after administration. Your total appointment will be
somewhat longer to allow time for pre-treatment assessment, administration, monitoring, and discharge
evaluation.
Do I take SPRAVATO® at home?
No. SPRAVATO® must be administered in a certified healthcare setting under the supervision of a
healthcare provider.
Can I drive home afterward?
No. You will need transportation home following treatment. You should not drive or perform activities
requiring complete alertness until the next day after a restful sleep.
Will my insurance cover SPRAVATO®?
Many insurance plans provide coverage when medical-necessity requirements are met. Coverage and
patient responsibility vary by plan. AmoreMedix can verify benefits and assist with prior authorization when
required.
How do I know if I qualify?
Schedule an initial consultation. We will review your depression treatment history, medical history,
medications, insurance requirements, and other relevant factors to determine whether SPRAVATO® may
be appropriate.
